S&P 500 Cons Disc Sector SPDR (XLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | XLY | NVO | JNJ | ||
| Company | S&P 500 Cons Disc Sector SPDR | Novo Nordisk A/S ADR | Johnson & Johnson | ||
| Price Information | |||||
| Exchange | NYSE Arca | NYSE | NYSE | ||
| Open | 233.97 | 87.17 | 145.51 | ||
| High | 234.45 | 88.06 | 146.37 | ||
| Low | 232.57 | 86.87 | 145.09 | ||
| Last | 233.60 | 87.65 | 145.58 | ||
| Change | -0.87 | +0.28 | -0.27 | ||
| % Change | -0.37% | +0.32% | -0.19% | ||
| Volume | 2,055,400 | 6,292,000 | 4,656,900 | ||
| 20-Day Average Volume | 3,400,440 | 8,032,940 | 8,499,920 | ||
| Previous Close | 234.47 | 87.37 | 145.85 | ||
| Industry | Finance - Investment Funds | Large Cap Pharma | Large Cap Pharma | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 230.49 | 104.05 | 148.25 | ||
| 20-Day Raw Stochastic | 67.84% | 19.83% | 20.39% | ||
| 20-Day Relative Strength | 63.21% | 29.51% | 36.61% | ||
| Weighted Alpha | +38.28 | -29.74 | -9.33 | ||
| Today's Opinion | 100% Buy | 100% Sell | 88% Sell | ||
| Previous Opinion | 100% Buy | 100% Sell | 88% Sell | ||
| Last Month's Opinion | 100% Buy | 100% Sell | 24% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.17% since 12/18/24 | -17.28% since 12/18/24 | +0.57% since 12/18/24 | ||
| Low | 225.50 on 12/20/24 | 81.50 on 12/20/24 | 142.75 on 12/20/24 | ||
| High | 234.50 on 12/24/24 | 104.75 on 12/19/24 | 146.37 on 12/26/24 | ||
| 1-Month | |||||
| %Chg | +5.64% since 11/26/24 | -17.41% since 11/26/24 | -5.79% since 11/26/24 | ||
| Low | 219.51 on 11/27/24 | 81.50 on 12/20/24 | 142.75 on 12/20/24 | ||
| High | 240.28 on 12/18/24 | 112.52 on 12/11/24 | 156.63 on 11/27/24 | ||
| 3-Month | |||||
| %Chg | +16.49% since 09/26/24 | -29.49% since 09/26/24 | -9.80% since 09/26/24 | ||
| Low | 193.03 on 10/23/24 | 81.50 on 12/20/24 | 142.75 on 12/20/24 | ||
| High | 240.28 on 12/18/24 | 121.34 on 09/27/24 | 166.75 on 10/15/24 | ||
| 6-Month | |||||
| %Chg | +27.42% since 06/26/24 | -38.99% since 06/26/24 | -0.84% since 06/26/24 | ||
| Low | 166.48 on 08/05/24 | 81.50 on 12/20/24 | 142.75 on 12/20/24 | ||
| High | 240.28 on 12/18/24 | 145.99 on 07/01/24 | 168.85 on 09/04/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 23,845,582 | 392,075,712 | 351,151,840 | ||
| Shares Outstanding, K | 101,653 | 4,487,532 | 2,407,623 | ||
| Annual Sales | 0 | 33,724,300,000 | 85,159,000,000 | ||
| Annual Net Income | 0 | 12,150,770,000 | 35,153,000,000 | ||
| Last Quarter Sales | N/A | 10,511,240,000 | 22,471,000,000 | ||
| Last Quarter Net Income | N/A | 4,024,170,000 | 2,694,000,000 | ||
| 60-Month Beta | 1.18 | 0.40 | 0.51 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 0.90 on 11/06/24 | 2.42 on 10/15/24 | ||
| Latest Earnings Date | N/A | 01/29/25 | 01/22/25 | ||
| Most Recent Dividend | 0.433 on 12/23/24 | 0.362 on 08/16/24 | 1.240 on 11/26/24 | ||
| Next Ex-Dividends Date | 12/23/24 | 08/16/24 | 11/26/24 | ||
| Ratios | |||||
| Price/Earnings ttm | 24.20 | 28.71 | 14.19 | ||